![K. Min](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
K.
Chris Min is a former Senior Medical Director-Neurology at Bluerock Therapeutics, Inc. and a former VP, Head-Medical & Clinical Development at Enterin, Inc. In 2023, he served as the Chief Medical Officer at Longeveron, Inc. Dr. Min holds an undergraduate degree from Harvard University and doctorate degrees from The Rockefeller University and Weill Cornell Medical College.
Ehemalige bekannte Positionen von K. Min
Unternehmen | Position | Ende |
---|---|---|
LONGEVERON INC. | Vorstandsvorsitzender | 01.03.2023 |
Enterin, Inc.
![]() Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2021 |
Bluerock Therapeutics, Inc. | Corporate Officer/Principal | - |
Ausbildung von K. Min
Harvard University | Undergraduate Degree |
The Rockefeller University | Doctorate Degree |
Weill Cornell Medical College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
LONGEVERON INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Enterin, Inc.
![]() Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
Bluerock Therapeutics, Inc. |